Rocket One Inc. Common Stock (NASDAQ:RKTO) Stock Short Interest Declines 52.8%

Posted by Stanley Muller on Oct 15th, 2026

Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) was the target of a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 992,927 shares, a decline of 52.8% from the September 15th total of 2,105,431 shares. Based on an average daily volume of 496,261 shares, the short-interest ratio is currently 2.0 days. Approximately 4.8% of the shares of the company are sold short.

Rocket One Inc. Common Stock Trading Up 0.9%

Shares of RKTO traded up $0.00 during trading hours on Thursday, reaching $0.54. 154,869 shares of the stock traded hands, compared to its average volume of 4,207,880. The company has a market cap of $11.99 million, a P/E ratio of -0.66 and a beta of 0.90. The company’s 50-day moving average price is $0.72 and its two-hundred day moving average price is $0.83. Rocket One Inc. Common Stock has a 52-week low of $0.49 and a 52-week high of $2.45.

Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.19) earnings per share (EPS) for the quarter.

Analyst Upgrades and Downgrades

Several research firms have recently commented on RKTO. Weiss Ratings downgraded Rocket One Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday. Wall Street Zen downgraded Rocket One Inc. Common Stock from a “sell” rating to a “strong sell” rating in a research note on Sunday, August 16th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $5.00.

Get Our Latest Analysis on RKTO

Institutional Trading of Rocket One Inc. Common Stock

An institutional investor recently raised its stake in Rocket One Inc. Common Stock stock. Lido Advisors LLC boosted its holdings in shares of Rocket One Inc. Common Stock (NASDAQ:RKTO – Free Report) by 100.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 39,000 shares of the company’s stock after purchasing an additional 19,500 shares during the quarter. Lido Advisors LLC owned about 0.20% of Rocket One Inc. Common Stock worth $33,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 7.08% of the company’s stock.

Rocket One Inc. Common Stock Company Profile

(Get Free Report)

Hoth Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation, which is in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases; and HT-002, a novel peptide for treating COVID-19.